Skip to content

Certipharm: what changed

BE 0754.702.164NACE 82.990, Other business support servicesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€91,689
2024 · €59,104+€32,585
Equity
€102,793
2024 · €61,104+€41,689
Cash
€136,612
2024 · €46,976+€89,636
Balance sheet total
€157,372
2024 · €65,270+€92,102

Largest movements

2024 to 2025
Assets
  • Cash +€89,636

    up €89,636 (+191%), from €46,976 to €136,612

    mainly Net result for the year (+€91,689) and Other debts (+€50,680)

  • Receivables within one year +€3,423

    up €3,423 (+22.0%), from €15,560 to €18,983

Equity and liabilities
  • Other debts +€50,680

    up €50,680 (+28,314%), from €179 to €50,859

  • Reserves +€41,689

    up €41,689 (+70.5%), from €59,104 to €100,793

Income statement
  • Gross operating margin +€38,957

    up €38,957 (+45.5%), from €85,612 to €124,569

  • Taxes +€6,505

    up €6,505 (+26.0%), from €25,000 to €31,505

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €59,104
Gross operating margin +€38,957
Other operating charges +€130
Financial income +€0
Financial charges +€3
Taxes -€6,505
Result 2025 €91,689
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€140,505
Investment -€869
Financing -€50,000
Cash 2024 €46,976
Net result for the year +€91,689
Depreciation +€529
Receivables within one year -€3,423
Deferred charges and accrued income +€1,297
Trade debts +€127
Tax, wage and social debts -€394
Other debts +€50,680
Investment in fixed assets (net) -€869
Contributions, distributions and other -€50,000
Cash 2025 €136,612
brings cash intakes cash out
Every line side by side 33 lines
Line Code 2024 2025 Change %
Total assets 20/58 €65,270 €157,372 +€92,102 +141%
Fixed assets 21/28 €1,438 €1,778 +€340 +23.7%
Tangible fixed assets 22/27 €1,438 €1,778 +€340 +23.7%
Furniture and vehicles 24 €1,438 €1,778 +€340 +23.7%
Current assets 29/58 €63,833 €155,594 +€91,762 +144%
Amounts receivable within one year 40/41 €15,560 €18,983 +€3,423 +22.0%
Trade receivables 40 €15,560 €18,983 +€3,423 +22.0%
Cash at bank and in hand 54/58 €46,976 €136,612 +€89,636 +191%
Deferred charges and accrued income 490/1 €1,297 - -€1,297
Total equity and liabilities 10/49 €65,270 €157,372 +€92,102 +141%
Equity 10/15 €61,104 €102,793 +€41,689 +68.2%
Contributions 10/11 €2,000 €2,000 = 0.0%
Reserves 13 €59,104 €100,793 +€41,689 +70.5%
Distributable reserves 133 €59,104 €100,793 +€41,689 +70.5%
Amounts payable 17/49 €4,166 €54,580 +€50,413 +1,210%
Amounts payable within one year 42/48 €4,166 €54,580 +€50,413 +1,210%
Trade debts 44 - €127 +€127
Suppliers 440/4 - €127 +€127
Taxes, remuneration and social security 45 €3,987 €3,593 -€394 -9.9%
Taxes 450/3 €3,987 €3,593 -€394 -9.9%
Other amounts payable 47/48 €179 €50,859 +€50,680 +28,314%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €529 €529 = 0.0%
Other operating charges 640/8 €906 €776 -€130 -14.3%
Gross operating margin 9900 €85,612 €124,569 +€38,957 +45.5%
Operating profit (loss) 9901 €84,177 €123,264 +€39,087 +46.4%
Financial income 75/76B - €0 +€0
Recurring financial income 75 - €0 +€0
Financial charges 65/66B €73 €70 -€3 -4.2%
Recurring financial charges 65 €73 €70 -€3 -4.2%
Profit (loss) for the period before taxes 9903 €84,104 €123,194 +€39,090 +46.5%
Income taxes 67/77 €25,000 €31,505 +€6,505 +26.0%
Profit (loss) for the period 9904 €59,104 €91,689 +€32,585 +55.1%
Profit (loss) for the period to be appropriated 9905 €59,104 €91,689 +€32,585 +55.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€355,136 to €476,631

Midpoint €405,759 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €102,793
Capitalised earnings €607,479 to €850,470
Indication €355,136 to €476,631

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€102,793
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€102,793

Capitalised earnings

net result for the year (9904)
2025
€91,689
2024
€59,104
2023
€104,348
2022
€77,028
2021
€113,552
Average result
€85,047
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€607,479 / €708,725 / €850,470

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.